| CJC-1295 (No DAC) C₁₅₅H₂₅₆N₄₄O₄₆, is commonly referred to as Mod GRF (1–29), is a modified growth hormone–releasing hormone analog developed without Drug Affinity Complex (DAC) attachment to maintain short-duration activity. It is structurally altered through multiple substitutions to improve molecular stability and receptor interaction relative to native GHRH (1–29). In experimental models, this peptide engages the GHRH receptor and promotes adenylate cyclase–dependent cAMP signaling, supporting investigation of somatotropic pathway activation. As a result, it is widely applied in laboratory studies examining peptide behavior, receptor dynamics, and regulatory mechanisms of pituitary hormone signaling.
Supplied in a 3 mL vial as a lyophilized (freeze-dried) powder requiring reconstitution with a laboratory diluent. For laboratory research use only. Not for human or veterinary consumption. |
CJC-1295 (No DAC) ― 5mg
$55.00
58 in stock
RELATED PRODUCTS
Cagrilintide ― 5mg
GHK-Cu ― 100mg
GHK-Cu ― 50mg
GHK-Cu (3 Pack)― 50mg
GHK-Cu (C₁₄H₂₄N₆O₄·Cu²⁺) is a copper-coordinated peptides complex formed from the tripeptide Gly-His-Lys chelated with divalent copper ions. In laboratory research, it is examined for its involvement in extracellular matrix dynamics and peptides-mediated cellular signaling processes. Experimental studies have shown that GHK-Cu influences collagen-related pathways, gene regulatory activity, and copper-dependent redox systems, making it a useful reference compound for research into tissue remodeling, metalloprotein interactions, and regenerative biochemical mechanisms.
Supplied in a 3 mL vial as a lyophilized (freeze-dried) powder requiring reconstitution with a laboratory diluent. For laboratory research use only. Not for human or veterinary consumption.
